Research of pharmaceutical market of the foam aerosols
Journal Title: Фармацевтичний журнал - Year 2016, Vol 1, Issue 1
Abstract
Medical and pharmaceutical foams are therapeutics systems which determine foams as a class of medicines systems modified by release of active pharmaceutical ingredients. Foams are structured disperse system in the form of accumulation of bubbles of gas (dispersed phase) which are divided by thin layers of liquid disperse environment and are designed for delivery of medicines to target organs (skin, mucous membranes etc.). Existing nomenclature of pharmaceutical foam drugs doesn’t allow complete resolution of complicated tasks regarding qualified medical aid. Therefore, it is very important to provide further researches in this field along with further development of the foam aerosols. The aim of this research is assessment of the pharmaceutical market of Ukraine in terms of availability of foam drug in form of aerosol. Marketing researches established that on pharmaceutical market of Ukraine (on 01. 05. 2015) 21 types of drugs have been registered in form of aerosols which are manufactured by 6 countries worldwide. Fourteen of them are manufactured in Ukraine. Analysis of aerosols divided into pharmaceutical groups has found that most of them are treatment against wounds and sores (10 aerosols). Treatments in forms of aerosols with active ingredients such as Decametoxine, Dexpantenol, Phenoterol are manufactured in Ukraine. Treatment with Dexpantenol, Zinc pirithioni, Salbutamol and Budesonit are imported to Ukraine by foreigner pharmaceutical companies. It has been found that Ukrainian market is sufficiently supplied by local pharmaceutical factories but such treatment as Scincap and Budenofalc are not manufactured in Ukraine. Besides, it was found out that pharmaceutical product in form of aerosols for prevention and treatment of gynecological diseases are not manufactured in Ukraine as well.
Authors and Affiliations
A. O. Drozdova, O. S. Soloviov
Keywords
Related Articles
- EP ID EP561397
- DOI -
- Views 58
- Downloads 0
Real world evidence analysis of prescribing practice of medicines for the treatment of common gynecological diseases in Ukraine
Increasingly, effectiveness data obtained from RWE are required to make reimbursement decisions through coverage with evidence development schemes in line with current WHO recommendations. Due to the reforming process in...
Сhronic toxicity testing complex phytopoliextraction of sedative action
Development and introduction in medical practice sedative meals on the base of complex phytopoliextracts from the domestic medical plants permitted for medical application is highly actual because of incrised incidence o...
Luminescent determination of residues of trazodon hydrochloride and melatonin after cleaning pharmaceutical equipment
A prerequisite for ensuring the quality of medicines is their production in accordance with the rules of GMP (Good Manufacturing Practice for Medicinal Products), one of the most important requirements of which is equipm...
Synthesis and physical-chemical properties of 8-bromo-3-methyl-7-α-methylbenzylxanthine derivatives
The level of modern pharmaceutical science development is determined by the introduction in medical practice of new effective and non-toxic drugs. The problem of new drugs search depends on the presence in the arsenal of...
Synthesis, physical-chemical and biological properties of 8-R-thioderivatives of 1-benzyltheobromine
Key way for creating new medicinal drugs is structural modification of known and existent natural compounds with high biological activity. In this aspect researchers’ attention is drawn by xanthine derivatives which appe...